GlassScriptPhysician profile
John Daniel Fruge
NPI 1154862480
$4,139.87
in general payments reported to CMS, 2019-2025
14 companies · $840 in 2025
The $840 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.50 · 2022: $1,502 · 2023: $1,234 · 2024: $531 · 2025: $840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,074 · Travel and Lodging: $530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,074.35 |
| Travel and Lodging | $530.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,753.97 | 2022-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Stryker Corporation | $855.99 | 2023 | Spinejack, Multigen 2, Ivas |
| Abbott Laboratories | $483.16 | 2023-2024 | Eterna |
| Saluda Medical Americas, INC. | $293.82 | 2023-2025 | Evoke Scs, Evoke |
| Spr Therapeutics, INC | $277.64 | 2025 | Sprint Pns System |
| Globus Medical, INC. | $149.05 | 2025 | Vyrsa V1, Senza |
| Medtronic, INC. | $108.51 | 2024-2025 | Intellis Adaptivestim, Synchromedii |
| Zynex Medical, INC. | $60.35 | 2025 | Nexwave |
| Pacira Pharmaceuticals Incorporated | $38.95 | 2023-2025 | Iovera, Exparel, Zilretta |
| Nevro Corp. | $34.78 | 2024 | Senza |
| Biohaven Pharmaceuticals, INC. | $33.50 | 2021 | |
| Collegium Pharmaceutical, INC. | $18.52 | 2023 | Belbuca |
| Fidia Pharma USA INC. | $16.57 | 2024 | Hyalgan, Hymovis, Triluron |
| Vertex Pharmaceuticals Incorporated | $15.06 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Fruge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.